Time is right to develop a consensus Human Skin Cell Atlas, according to leading dermatology experts
Philadelphia | August 21, 2023
A review published in the Journal of Investigative Dermatology is the first step towards establishing an inclusive reference work to single-cell composition of normal human skin
As a single organ, our skin is able to perform a broad repertoire of vital functions. Dermatology experts call for a reference guide to single-cell composition of normal human skin, which is still lacking. A grassroots movement to establish a Human Skin Cell Atlas is taking shape, as reported in a review(opens in new tab/window) in the Journal of Investigative Dermatology(opens in new tab/window), published by Elsevier. A global team of experts has outlined a roadmap as a first step towards creating a comprehensive and inclusive reference work on this important topic.
Our skin performs vital functions, such as protecting us from external threats (pathogens, UV rays), regulating our body's temperature, giving us our sense of touch, and enabling us to express ourselves via cranial and facial hair. Skin is also anatomically diverse across the body, a feature biologists call “regional specificity.” For instance, hairless skin on our palms with complex fingerprints is dramatically distinct from skin with hair on our scalp. To perform its numerous functions and to maintain prominent regional specificity, skin consists of several distinct cell types, which in turn, each contain numerous cell states.
Using single-cell RNA-sequencing (scRNA-seq) technology, researchers can study gene expression signatures of many individual cells in tissues and then bioinformatically evaluate how they work together to perform tissue functions.
Co-lead author Maksim Plikus, PhD, from the Department of Developmental and Cell Biology at the University of California, Irvine, explains, "Many co-authors on this review were early adopters of single-cell technologies. This technology requires in-depth understanding of bioinformatic approaches and detailed knowledge of conserved gene expression features of distinct skin cell types. As such, the research field has now reached a critical inflection point when a reference guide to single-cell composition of normal human skin is acutely needed."
Responding to this critical need, the Human Cell Atlas is an international grassroots effort to generate a comprehensive single-cell reference of every human organ.
Co-lead author Maria Kasper, PhD, from the Department of Cell and Molecular Biology at the Karolinska Institute, adds, "Because we are passionate about human skin biology and versed in single-cell methods, we put together this review as a guide for achieving the goal to generate the Human Skin Cell Atlas (HSCA). This review, a roadmap of a kind, will be the first step, followed by a joint effort to generate the actual atlas."
The initial atlas will be based on sequenced cells collected from healthy human skin. The authors envision that this atlas would then be used as the basis to uncover both conserved and varying human skin cell populations as well as molecular differences that arise upon skin diseases. Once complete and up and running as an open-source online resource, it will be possible to utilize a consensus atlas for semi-automated mapping of patient-specific changes in any future scRNA-seq data. In addition, in the future, the HSCA reference could be used to support personalized medicine, such as single-cell-based personalized diagnostics of skin diseases.
The review is a collection of knowledge from skin experts ranging from basic scientists to clinicians and from trainees to seasoned principal investigators. It outlines key considerations for the atlas in order to comprehensively represent skin cells across five scales: spatial, temporal, gender, ancestral origin, and wound response scales.
As part of the roadmap to develop the HSCA, the authors also emphasize the importance of global representation, reflecting skin of the broader human population, rather than that of only selected human groups that are typically over-represented in biomedical research. They further highlight that for the HSCA to be balanced, scientists need to comprehensively consider unintentional biases that can be easily introduced during single-cell data collection and generation. Such biases include under-representation of skin from minority groups, difficult-to-sample body sites, and technical consistency in generating scRNA-seq data among different laboratories.
Finally, a standardized metadata template is proposed to collect detailed information when generating new scRNA-seq datasets.
Notes for editors
The article is “A Roadmap for a Consensus Human Skin Cell Atlas and Single-Cell Data Standardization,” by Axel A. Almet, Hao Yuan, Karl Annusver, Raul Ramos, Yingzi Liu, Julie Wiedemann, Dara H. Sorkin, Ning Xu Landén, Enikö Sonkoly, Muzlifah Haniffa, Qing Nie, Beate M. Lichtenberger, Malte D. Luecken, Bogi Andersen, Lam C. Tsoi, Fiona M. Watt, Johann E. Gudjonsson, Maksim V. Plikus, and Maria Kasper (https://doi.org/10.1016/j.jid.2023.03.1679(opens in new tab/window)). It appears online in advance of the Journal of Investigative Dermatology, volume 143, issue 9 (September 2023), published by Elsevier(opens in new tab/window).
The article is openly available at https://www.jidonline.org/article/S0022-202X(23)01982-6/fulltext(opens in new tab/window).
The authors would like to thank the LEO foundation, Chan Zuckerberg Initiative, National Institutes of Health, Wellcome Trust, European Union’s Horizon 2020 Programme, and Simons Foundation, among others, for their funding support, making this work possible. The full funding statement is available in the original article.
Full text of this review is also available to credentialed journalists upon request; contact Theresa Monturano at +1 215 239 3711 or [email protected](opens in new tab/window). Journalists wishing to interview the authors should contact the Maksim Plikus, PhD, at [email protected](opens in new tab/window), or Maria Kasper, PhD, at [email protected](opens in new tab/window).
About Journal of Investigative Dermatology
The Journal of Investigative Dermatology (opens in new tab/window)(JID) is the official journal of the Society of Investigative Dermatology and the European Society for Dermatological Research. JID publishes high impact reports describing original research related to all aspects of cutaneous biology and skin diseases. Descriptions of important findings that result from basic, translational, or clinical research are published. Clinical research can include, but is not limited to, interventional trials, genetics studies, epidemiology, and health services research. www.jidonline.org(opens in new tab/window)
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, academic leaders, funders, R&D-intensive corporations, doctors, and nurses.
Elsevier employs 9,000 people worldwide, including over 2,500 technologists. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, medical education, and nursing education. Researchers and healthcare professionals rely on over 2,800 journals, including The Lancet(opens in new tab/window) and Cell(opens in new tab/window); 46,000+ eBook titles; and iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation(opens in new tab/window) and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.
Elsevier is part of RELX(opens in new tab/window), a global provider of information-based analytics and decision tools for professional and business customers.